Bernstein has reiterated its Outperform rating on a major global pharmaceutical firm, urging investors to "lean into" the drugmaker's pipeline ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE